Rapid diagnostic testing for malaria has revealed that most febrile patients in Africa and Asia do not have malaria. FIEBRE will find out what they have and how to treat them.
Funded by the UK Department for International Development, FIEBRE collaborators include LSHTM, Liverpool School of Tropical Medicine, Universities of Oxford, Barcelona and Otago, and partners in Laos, Malawi, Mozambique, Myanmar and Zimbabwe.
Study protocols, standard operating procedures, data collection tools and related materials will be made available as they are finalised and approved.
The objective of FIEBRE is to provide evidence:
- on the most common infectious causes of fever;
- on antibiotic susceptibility of bacterial causes;
- on how local perceptions of fever affect treatment practices including the use of diagnostics and antimicrobial drugs;
- to inform clinical guidelines and algorithms on how to manage non-malarial fevers.
The FIEBRE study will help to fill the gaps in evidence by means of a multi-centre study in countries with a high burden of infectious disease from which few or no data are available. The clinical and laboratory components of the study will focus on detecting infections that are treatable and/or preventable. Ethnographic work with community members, prescribers and public health workers will seek to understand how fever is understood by different communities of practice, and how this affects treatment practices.
The results will help to inform updated, evidence-based algorithms for the management of febrile illness, and provide data that may be used to design new diagnostics and rational approaches to disease surveillance. These outputs will ultimately help health systems and providers to provide more appropriate care to patients and lead to better clinical outcomes.
FIEBRE is funded by the UK Department for International Development. It is a multi-centre study conducted by the LSHTM, Liverpool School of Tropical Medicine, Barcelona Institute for Global Health (ISGlobal), Universities of Oxford and Otago, and partner institutions in Lao PDR, Malawi, Mozambique, Myanmar and Zimbabwe, and collaborating reference laboratories.
- ISGlobal – Barcelona Institute of Global Health
- Liverpool School of Tropical Medicine (LSTM)
- University of Otago, New Zealand
- University of Oxford
- Lao - Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU)
- Malawi - Malawi-Liverpool Wellcome Trust Research Programme (MLW)
- Mozambique - Centro de Investigacao em Saude de Manhica (CISM)
- Myanmar - University of Medicine 1, Yangon
- Zimbabwe - Biomedical Research and Training Institute (BRTI)
Meet the team
Prof David Mabey, Principal Investigator
Dr Amit Bhasin, Programme Manager
Dr John Bradley, Co-investigator, Statistician
Dr Heidi Hopkins, Co-investigator, Scientific Programme Coordinator
Sham Lal, Co-investigator, Electronic Data Management System
Ruth Lorimer, Communications Officer
Dr Chrissy Roberts, Co-investigator, ODK specialist and Laboratory Lead
Karen Slater, Administrative support
Dr Shunmay Yeung, Co-investigator, Paediatric Lead
The principal investigators for the partners are:
For more details about each country team see the Where we work section.
Social science team
Dr Clare Chandler, Co-investigator, Social Science Lead
Dr Justin Dixon, Co-investigator, Social Scientist
Dr Coll Hutchison, Co-investigator, Social Scientist
Pat Ng, Project Manager, Social science team
Eleanor MacPherson, Social Science lead (LSTM)
Chawanangwa Mahebere Chirambo, Social Science Co-lead and PhD Student
Yuzana Khine Zaw, PhD Student
Salome Manyau, Social Science Lead and PhD Student
An External Advisory Committee (EAC) has been established to provide scientific oversight of the FIEBRE study. The members of the EAC are:
Prof Chris Whitty (Chair), Interim Government Chief Scientific Adviser & Professor of Public and International Health, London School of Hygiene & Tropical Medicine, UK
Dr David Meya, Associate Professor, College of Health Sciences, Makerere University, Uganda
Dr T Jacob John, Professor Emeritus, Christian Medical College, (CMC) Vellore, India
Dr Amanda Walsh, Senior Scientist, Emerging Infections and Zoonoses, National Infection Service, Public Health England, UK
The FIEBRE study sites are in Laos, Malawi, Mozambique, Myanmar and Zimbabwe.
The Mahidol Oxford Tropical Medicine Research Unit (MORU) develops effective and practical means of diagnosing and treating malaria and other neglected diseases such as melioidosis, typhus, TB and leptospirosis. MORU was established in 1979 as a research collaboration between Mahidol University (Thailand), Oxford University (UK) and the Wellcome Trust UK. It is a network of a diversity of subunits including the Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Lao PDR (LOMWRU). This is a small clinical tropical medicine research group based at Mahosot Hospital, Vientiane . LOMWRU builds diagnostic, clinical and research capacity to help improve global, regional and Lao public health. LOMWRU’s main areas of research interest are in the diagnosis, epidemiology and treatment of malaria, rickettsial infections, leptospirosis, melioidosis, community-acquired septicaemia, central nervous system infections, the causes of acute fevers and public health aspects of medicine quality problems.
The Malawi site will be Chikwawa district in the southern region of Malawi. Chikwawa district is 5,000 km2 with a population of 350,000 and is served by Chikwawa Hospital.
The work will be based out of the Malawi-Liverpool Wellcome Trust Clinical Research Programme (MLW) . Established in 1995, MLW is an internationally-recognised health research institution led by Malawian and international scientists with the aim of improving the health of people in sub-Saharan Africa. MLW is built around laboratories, located at Queen Elizabeth Central Hospital, in Blantyre.
The principal investigator is Dr Nicholas Feasey and the study doctor is Dr Ed Green.
CISM was established in 1996 with the objective of conducting biomedical research in those diseases that affect the most poor and vulnerable. The Centre includes a fully equipped laboratory including parasitology, haematology, biochemistry, microbiology, (including biosafety level III premises), molecular biology (including PCR and RT-PCR) and immunology. CISM has been running a Demographic Surveillance System (DSS) since 1996, covering the whole district’s population and it set up a morbidity surveillance system at Manhiça District Hospital (MDH) in 1998. Overall, data on over 70,000 paediatric admissions and more than 1.2 million outpatient visits have been collected in the past 18 years. CISM’s other activities include: malaria screening, microbiological surveillance; pneumonia surveillance and conducting studies on issues with an important impact on public health policies in the country.
The study will be conducted in the district of Manhiça (population 182,000 inhabitants, 2300 km2), a rural area located 90 km away from the capital Maputo. MDH acts as the referral health facility for the area.
The study’s Principal Investigator at the site is Professor Quique Bassat, supported by co-investigators Dr Antonio Sitoe, Dr Lola Madrid, Dr Rubao Bila, in addition to a larger team of Mozambican-based supporting staff.
Researchers from the University of Medicine 1, Yangon, Myanmar, will be implementing research activities for the FIEBRE study with colleagues at Thanlyin District Hospital through the longstanding University of Otago – University of Medicine 1 Collaboration. The research team will be based at Thanlyin District Hospital a busy district hospital in south Yangon.
The Myanmar Principal Investigator is Professor Wah Win Htike, Professor and Head, Department of Microbiology, University of Medicine 1. She leads a team including Professor Hla Hla Win, Professor and Head, Department of Preventive and Social Medicine and Professor Zaw Lynn Aung, Professor and Head, Department of Medicine, University of Medicine 1. Dr Win Thandar Oo, a University of Medicine 1 medical microbiologist, will study towards a University of Otago PhD linked to the work at the Myanmar FIEBRE site.
Professor John Crump, McKinlay Professor of Global Health and Co-Director of the Otago Global Health Institute, University of Otago, will support this work. Professor Crump has been instrumental in the design and development of the FIEBRE study, and has coordinated reference laboratory engagement.
The researchers in Zimbabwe are based at the Biomedical Research and Training Institute (BRTI) in Harare. Established in 1995, the BRTI provides effective and professional research facilities including laboratory facilities for molecular diagnostics, micro-biology, serology, TB and immunology. BRTI aims to improve health and quality of life in Africa through conducting research and training. Its role is to provide the infrastructural support that researchers in all aspects of health need to become effective in influencing policy.
The study site incorporates major hospitals in Harare (urban setting) Harare Central Hospital (HCH) and Chitungwiza Hospital. These hospitals have both inpatient and outpatients care of all age groups with patients referred from local clinics and provincial hospitals. The hospitals serve urban and peri-urban communities in southern Harare. In addition, outpatients will be recruited from polyclinics in south-western Harare.
The BRTI team is led by Professor Rashida Ferrand (Principal investigator) and comprises: Dr Ioana Olaru (Study coordinator), Ethel Dauya (Field manager), Tsitsi Bandason (Data manager), Salome Manyau (Social science lead), Beauty Makamure (Laboratory manager) and Tendai Muchena (Administrator). Partners include the Department of Medicine and Paediatrics at Harare Hospital and Chitungwiza Hospital, the University of Zimbabwe and Harare City Health Services.
Publications, research and data produced and contributed to by FIEBRE team members is available including:
- Journal articles
- Conferences, workshops and presentations
- Books, chapters and sections
- Seminars and lectures